• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Azenta, Inc. - Common Stock (NQ:AZTA)

37.87 +0.10 (+0.26%)
Delayed Quote Updated: 4:00 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 663,252
Open 37.77
Bid (Size) 37.25 (100)
Ask (Size) 37.87 (100)
Prev. Close 37.77
Today's Range 37.18 - 38.40
52wk Range 15.93 - 46.41
Shares Outstanding 53,918,934
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
October 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment
October 05, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how drug development input... 
Via StockStory

Performance

52-Week Range 18.4% below 52-week high
37.87
15.9352W Low 46.4152W High
1 Week 18.4% below 1-week high
34.921W Low 46.411W High

Azenta, Inc. - Common Stock (AZTA) traded between $15.93 and $46.41 over the past 52 weeks and last traded at $37.87, 18.4% below its 52-week high. Over the past week it ranged between $34.92 and $46.41.

Past 12 Months
-3.8%
+18.2%
+45.4%
+62.3%
+13.4%
+24.1%
1W -$1.48
1M +$5.83
3M +$11.82
6M +$14.54
YTD +$4.48
1Y +$7.35

AZTA was +24.1% over the past year, +62.3% over six months, +13.4% year to date, -3.8% in the last week.

12 Months vs Market
AZTA
+24.1%
DIA
+12.1%
SPY
+17.3%
QQQ
+23.5%
IWM
+13.2%

Over the past 12 months AZTA returned +24.1% versus DIA (Dow) +12.1%, SPY (S&P 500) +17.3%, QQQ (Nasdaq 100) +23.5% and IWM (Russell 2000) +13.2%.

Volume & Liquidity 0.75× 3-mo avg
Today 663,252 3-mo avg 885.9K
1W
1.4M
1M
1.2M
3M
885.9K
6M
983.4K
YTD
942.3K
1Y
873.0K

AZTA most recently traded 663,252 shares against a 3-month average daily volume of 885.9K.

More News

Read More
News headline image
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)
September 30, 2026
Via StockStory
Topics Economy
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
September 29, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
September 26, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
September 22, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Q2 Rundown: 10x Genomics (NASDAQ:TXG) Vs Other Life Sciences Tools & Services Stocks
September 21, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
September 15, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)
September 13, 2026
Via StockStory
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
September 08, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Q2 Earnings Highlights: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks
September 07, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
September 01, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
3 Healthcare Stocks We Keep Off Our Radar
September 01, 2026
Via StockStory
News headline image
Winners And Losers Of Q2: Illumina (NASDAQ:ILMN) Vs The Rest Of The Life Sciences Tools & Services Stocks
August 25, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
August 25, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group
August 25, 2026
Via StockStory
Topics Artificial Intelligence Credit Cards
News headline image
Why Azenta (AZTA) Stock Is Down Today
August 24, 2026
Via StockStory
News headline image
1 Momentum Stock for Long-Term Investors and 2 We Find Risky
August 19, 2026
Via StockStory
News headline image
Azenta (AZTA) Q3 2026 Earnings Call Transcript ↗
August 11, 2026
Via The Motley Fool
Topics Earnings
News headline image
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call
August 11, 2026
Via StockStory
Topics Earnings
News headline image
Azenta Q3 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics Earnings
News headline image
Azenta (NASDAQ:AZTA) Reports Upbeat Q2 CY2026
August 04, 2026
Via StockStory
News headline image
Azenta (AZTA) Reports Q2: Everything You Need To Know Ahead Of Earnings
August 02, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
3 Cash-Burning Stocks Walking a Fine Line
July 31, 2026
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Cabot Corporation Announces Planned Leadership Transition
July 30, 2026
From Cabot Corporation
Via GlobeNewswire

Frequently Asked Questions

Is Azenta, Inc. - Common Stock publicly traded?
Yes, Azenta, Inc. - Common Stock is publicly traded.
What exchange does Azenta, Inc. - Common Stock trade on?
Azenta, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Azenta, Inc. - Common Stock?
The ticker symbol for Azenta, Inc. - Common Stock is AZTA on the Nasdaq Stock Market
What is the current price of Azenta, Inc. - Common Stock?
The current price of Azenta, Inc. - Common Stock is 37.87
When was Azenta, Inc. - Common Stock last traded?
The last trade of Azenta, Inc. - Common Stock was at 10/13/26 04:00 PM ET
What is the market capitalization of Azenta, Inc. - Common Stock?
The market capitalization of Azenta, Inc. - Common Stock is 2.04B
How many shares of Azenta, Inc. - Common Stock are outstanding?
Azenta, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap